Bristol Myers Squibb today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic ...
Net income of $21.9 million, or $1.13 per diluted share, for the three months ended September 30, 2025 compared to net income of $19.4 million, ...
Report of Colgate University’s Task Force on Academic Freedom and Freedom of Expression.
Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Zebronics Pro Series Z ZEB-NBC 4S 2023 Laptop (12th Gen Core i5 / 8GB/ 512GB SSD/ Win11 Home) ₹ 34,990 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback